These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30203568)

  • 1. Avoiding inappropriate therapy of single-lead implantable cardioverter-defibrillator by using atrial-sensing electrodes.
    Kurt M; Jathanna N; Babady M; Schmidt J; Müller P; Gerguri S; Clasen L; Bejinariu A; Kelm M; Fürnkranz A; Makimoto H
    J Cardiovasc Electrophysiol; 2018 Dec; 29(12):1682-1689. PubMed ID: 30203568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study.
    Deisenhofer I; Kolb C; Ndrepepa G; Schreieck J; Karch M; Schmieder S; Zrenner B; Schmitt C
    J Cardiovasc Electrophysiol; 2001 Feb; 12(2):134-42. PubMed ID: 11232608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of single-lead implantable cardioverter-defibrillator with atrial sensing dipole to detect atrial fibrillation and to reduce inappropriate therapy according to atrial sensing ON or OFF: Rationale and design of the SMART-CONTROL study, a prospective multicenter randomized trial.
    Gwag HB; Kim HR; Park SJ; Kim J; Chung TW; Choi JH; Kim JY; Park KM; On YK; Kim JS
    Am Heart J; 2022 Sep; 251():25-31. PubMed ID: 35568193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Dx-AF study: a prospective, multicenter, randomized controlled trial comparing VDD-ICD to VVI-ICD in detecting sub-clinical atrial fibrillation in defibrillator patients.
    Shurrab M; Janmohamed A; Sarrazin JF; Ayala-Paredes F; Sturmer M; Williams R; Toal S; Lane C; Thorpe KE; Healey JS; Crystal E
    J Interv Card Electrophysiol; 2017 Oct; 50(1):57-63. PubMed ID: 28752228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and safety of an implantable cardioverter-defibrillator lead with a floating atrial sensing dipole.
    Safak E; Schmitz D; Konorza T; Wende C; De Ros JO; Schirdewan A;
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):952-62. PubMed ID: 23692262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
    JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical atrial fibrillation detection with a floating atrial sensing dipole in single lead implantable cardioverter-defibrillator systems: Results of the SENSE trial.
    Thomas G; Choi DY; Doppalapudi H; Richards M; Iwai S; Daoud EG; Houmsse M; Kanagasundram AN; Mainigi SK; Lubitz SA; Cheung JW
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1994-2001. PubMed ID: 31328298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Stability and Clinical Utility of Amplified Atrial Electrograms in a Single-Lead ICD System with Floating Atrial Electrodes.
    Worden NE; Alqasrawi M; Mazur A
    Pacing Clin Electrophysiol; 2016 Dec; 39(12):1327-1334. PubMed ID: 27778352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic experiences with a single lead dual chamber implantable cardioverter defibrillator system.
    Niehaus M; de Sousa M; Klein G; Korte T; Pfeiffer D; Walles T; Raymondos K; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2003 Oct; 26(10):1937-43. PubMed ID: 14516332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of a novel, single-lead atrial sensing system with a dual-chamber implantable cardioverter-defibrillator system in patients without antibradycardia pacing indications: results of a randomized study.
    Sticherling C; Zabel M; Spencker S; Meyerfeldt U; Eckardt L; Behrens S; Niehaus M;
    Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):56-63. PubMed ID: 21156772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
    Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
    Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter defibrillator system with floating atrial sensing dipole: a single-center experience.
    Iori M; Giacopelli D; Quartieri F; Bottoni N; Manari A
    Pacing Clin Electrophysiol; 2014 Oct; 37(10):1265-73. PubMed ID: 24809851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
    Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation.
    Sairaku A; Yoshida Y; Nakano Y; Kihara Y
    Int J Cardiol; 2013 Oct; 168(6):5273-6. PubMed ID: 23988302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of atrial sensing for new-onset atrial arrhythmias diagnosis and management in single-chamber implantable cardioverter-defibrillator recipients: Results from the THINGS registry.
    Biffi M; Iori M; De Maria E; Bolognesi MG; Placci A; Calvi V; Allocca G; Ammendola E; Carinci V; Boggian G; Saporito D; Grassini D; Giacopelli D; Statuto G; Ziacchi M
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):846-853. PubMed ID: 32064713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utilization of atrial sensing dipole in single lead implantable cardioverter defibrillator for detection of new-onset atrial high-rate episodes or subclinical atrial fibrillation: A systematic review and meta-analysis.
    Pung X; Hong DZ; Ho TY; Shen X; Tan PT; Yeo C; Tan VH
    J Arrhythm; 2022 Apr; 38(2):177-186. PubMed ID: 35387136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New generation cardioverter-defibrillator lead with a floating atrial sensing dipole: Long-term performance.
    Safak E; D Ancona G; Kaplan H; Caglayan E; Kische S; Öner A; Ince H; Ortak J
    Pacing Clin Electrophysiol; 2018 Feb; 41(2):128-135. PubMed ID: 29222869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lead-related complications in 340 patients with an implantable cardiverter/defibrillator].
    Schwacke H; Drögemüller A; Siemon G; Werling C; Saggau W; Senges J; Seidl K
    Z Kardiol; 1999 Aug; 88(8):559-65. PubMed ID: 10506392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Two for the Price of One": A Single-Lead Implantable Cardioverter-Defibrillator System with a Floating Atrial Dipole.
    Worden NE; Alqasrawi M; Krothapalli SM; Mazur A
    J Atr Fibrillation; 2016; 8(6):1396. PubMed ID: 27909501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.